Based on our current knowledge of the role of FoxP1, coupled with its concomitant increase in the skeletal muscle of mice bearing atrophy‐inducing tumours, we hypothesized that FoxP1 is a key mediator of cancer‐induced skeletal muscle wasting. The gene discussed is FOXP1; the disease is neoplasm.